Market News

CRINETICS PHARM (CRNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not h...

Barclays analyst Andrew Mok downgrades Community Health System (NYSE:CYH) from Equal-Weight to Underweight and maintains the price target from $3 t...

Keefe, Bruyette & Woods analyst Meyer Shields downgrades Cincinnati Financial (NASDAQ:CINF) from Outperform to Market Perform and raises the pr...

Helen Of Troy (NASDAQ:HELE) affirms FY2027 GAAP EPS guidance from $3.57-$4.18 to $3.57-$4.18 vs $2.34 analyst estimate..

Fiscal 2027 Annual OutlookConsolidated Net Sales: $1.759 billion to $1.831 billionHome & Outdoor Net Sales: $859 million to $884 millionBeauty &am...

Twist Bioscience leverages a semiconductor-based platform for DNA synthesis, driving scalable, AI-enabled drug discovery. Learn why TWST stock is a ho...

Keefe, Bruyette & Woods analyst Tommy McJoynt downgrades Neptune Insurance Hldgs (NYSE:NP) from Outperform to Market Perform and raises the pri...

Helen Of Troy (NASDAQ:HELE) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $(0.01) by 1800 percent. This ...

Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $101 to $110.

Johnson & Johnson has the momentum on its side and it is possible for the stock to increase further. Find out why JNJ stock is a hold.

Spire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a global provider of space-based data, analytics and intelligence, has succ...

Is NVDA stock a buy? BofA sees 78% upside and a $350 price target, calling Nvidia's massive moat 'unappreciated.' Read the full analysis.

Orange (ORANY) rated Hold: €14 entry target and $16 ADR price target.

Broadstone Net Lease, Inc. (NYSE:BNL) ("BNL", the "Company", "we", "our", or "us"), today announced that it ha...

The company doesn't plan to let its hefty data center investments go to waste.

(Bloomberg) -- Chip startup SambaNova Systems Inc. has raised $1 billion at an $11 billion valuation, underscoring investors’ conviction in rising dem...

Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $145 to $150.

Kelly’s Aging With AI Act aims to study how chatbots affect seniors, exploring AI benefits, risks, scams and fraud threats facing older adults.

Chamath Palihapitiya backs Elon Musk's SpaceX in AI race over competitors like OpenAI and Anthropic in the AI race.

Wells Fargo analyst Nathan Treybeck maintains ResMed (NYSE:RMD) with a Equal-Weight and lowers the price target from $227 to $225.